We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App




Automated Immunohematology Approaches Can Resolve Transplant Incompatibility

By LabMedica International staff writers
Posted on 13 Feb 2024

The persistent global shortage of donor organs has made the availability of ABO-compatible options a rarity for many hospitals, clinicians, and patients requiring organ transplants. More...

Despite this, advancements in desensitization therapies have made ABO-incompatible organ transplants not only possible but also as successful as compatible transplants. For instance, it has become common for patients with blood group O to receive organs from donors with type A2 blood, a subgroup of the A blood type that expresses fewer antigens. In such cases, the recipient's plasma can be treated using an immune-adsorption column to reduce the anti-A antibody concentration. Alternatively, when this method is not available, plasmapheresis can be utilized to exchange plasma and reduce the titer of anti-A. The reduction in antibody production can also be achieved through standard immunosuppressants and monoclonal antibodies like rituximab.

The titration of relevant ABO blood group antibodies is crucial in managing potentially incompatible organ transplants. The results from titrations help determine the likely success of a transplant procedure with the appropriate immunosuppressive treatment. Additionally, titrations are useful for monitoring antibody production post-transplant and assessing the risk of antibody-mediated rejection later on. Despite its clinical importance, many hospital labs do not routinely perform titration due to its labor-intensive nature, the high skill level required, and the difficulty in interpreting results. Manual titration also suffers from inherent imprecision due to variations in dilution preparation, dilution medium, red blood cell phenotype and the reaction reading which is difficult to standardize.

This issue is further exacerbated by a decrease in new immunohematologists entering the profession, leading to staffing shortages. This, coupled with increased workloads and financial constraints, makes it harder for hospital labs to offer this service and provide timely, definitive results. Consequently, there is a growing need for hematology labs to automate antibody titration to reduce turnaround times and improve result reliability. Automated immunohematology platforms, such as the IH-500 NEXT System from Bio-Rad Laboratories (Hercules, CA, USA), offer a viable solution, enabling local facilities to perform fully automated titrations. The adoption of automation in numerous immunohematology labs has proven successful, allowing them to provide results to doctors within hours on the same day a blood sample is drawn. This quick turnaround is crucial for efficiently allocating donated organs to needy patients and preventing antibody-mediated organ rejection.

Automation also offers greater precision and standardization, as it prevents technical and manual errors. This reduces the need for extensive training and experience, allowing a broader range of staff to perform antibody titrations and analyze the results. This shift can reduce the load on highly skilled specialists, further shortening the time to results. The widespread adoption of automated titration is essential for supporting future transplant services, ensuring that patients receive the critical organ donations they need as soon as possible.

Related Links:
Bio-Rad Immunohematology


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Glucose Tolerance Test
NERL Trutol
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New automated lab procedures can detect opioids in tiny amounts of blood (Photo courtesy of Tripathi Lab/Brown University)

First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns

As the opioid crisis continues to impact communities across the United States, laboratories encounter significant difficulties in accurately detecting opioid substances in individuals with opioid use disorder.... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Microbiology

view channel
Image: A prototype of the lateral flow test (Photo courtesy of University of Exeter)

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques

Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.